Follow
Jason D. Barbour, PhD
Jason D. Barbour, PhD
Chief Executive Officer & Technical Founder, Simpatica Medicine, Inc.
Verified email at simpaticamedicine.com - Homepage
Title
Cited by
Cited by
Year
Tim-3 expression defines a novel population of dysfunctional T cells with highly elevated frequencies in progressive HIV-1 infection
RB Jones, LC Ndhlovu, JD Barbour, PM Sheth, AR Jha, BR Long, ...
The Journal of experimental medicine 205 (12), 2763-2779, 2008
9152008
Virologic and immunologic consequences of discontinuing combination antiretroviral-drug therapy in HIV-infected patients with detectable viremia
SG Deeks, T Wrin, T Liegler, R Hoh, M Hayden, JD Barbour, NS Hellmann, ...
New England Journal of Medicine 344 (7), 472-480, 2001
8602001
Tryptophan Catabolism by Indoleamine 2,3-Dioxygenase 1 Alters the Balance of TH17 to Regulatory T Cells in HIV Disease
D Favre, J Mold, PW Hunt, B Kanwar, P Loke, L Seu, JD Barbour, ...
Science translational medicine 2 (32), 32ra36-32ra36, 2010
5992010
Tim-3 marks human natural killer cell maturation and suppresses cell-mediated cytotoxicity
LC Ndhlovu, S Lopez-Vergès, JD Barbour, RB Jones, AR Jha, BR Long, ...
Blood, The Journal of the American Society of Hematology 119 (16), 3734-3743, 2012
4962012
Critical loss of the balance between Th17 and T regulatory cell populations in pathogenic SIV infection
D Favre, S Lederer, B Kanwar, ZM Ma, S Proll, Z Kasakow, J Mold, ...
PLoS pathogens 5 (2), e1000295, 2009
4842009
Sustained CD4+ T Cell Response after Virologic Failure of Protease Inhibitor-Based Regimens in Patients with Human Immunodeficiency Virus Infection
SG Deeks, JD Barbour, JN Martin, MS Swanson, RM Grant
The Journal of infectious diseases 181 (3), 946-953, 2000
3682000
Poor CD4 T cell restoration after suppression of HIV-1 replication may reflect lower thymic function
L Teixeira, H Valdez, JM McCune, RA Koup, AD Badley, MK Hellerstein, ...
Aids 15 (14), 1749-1756, 2001
3382001
Duration and predictors of CD4 T-cell gains in patients who continue combination therapy despite detectable plasma viremia
SG Deeks, JD Barbour, RM Grant, JN Martin
Aids 16 (2), 201-207, 2002
2252002
Evolution of phenotypic drug susceptibility and viral replication capacity during long-term virologic failure of protease inhibitor therapy in human immunodeficiency virus …
JD Barbour, T Wrin, RM Grant, JN Martin, MR Segal, CJ Petropoulos, ...
Journal of virology 76 (21), 11104-11112, 2002
2082002
Persistence of primary drug resistance among recently HIV-1 infected adults
JD Barbour, FM Hecht, T Wrin, TJ Liegler, CA Ramstead, MP Busch, ...
Aids 18 (12), 1683-1689, 2004
1872004
Increased thymic mass and circulating naive CD4 T cells in HIV-1-infected adults treated with growth hormone
LA Napolitano, JC Lo, MB Gotway, K Mulligan, JD Barbour, D Schmidt, ...
Aids 16 (8), 1103-1111, 2002
1822002
Conferral of enhanced natural killer cell function by KIR3DS1 in early human immunodeficiency virus type 1 infection
BR Long, LC Ndhlovu, JR Oksenberg, LL Lanier, FM Hecht, DF Nixon, ...
Journal of virology 82 (10), 4785-4792, 2008
1422008
CD4+ T Cell Kinetics and Activation in Human Immunodeficiency Virus—Infected Patients Who Remain Viremic Despite Long-Term Treatment with Protease …
SG Deeks, R Hoh, RM Grant, T Wrin, JD Barbour, A Narvaez, D Cesar, ...
The Journal of infectious diseases 185 (3), 315-323, 2002
1382002
The relation between symptoms, viral load, and viral load set point in primary HIV infection
CF Kelley, JD Barbour, FM Hecht
JAIDS Journal of Acquired Immune Deficiency Syndromes 45 (4), 445-448, 2007
1342007
HIV-1 Vif adaptation to human APOBEC3H haplotypes
M Ooms, B Brayton, M Letko, SM Maio, CD Pilcher, FM Hecht, JD Barbour, ...
Cell host & microbe 14 (4), 411-421, 2013
1172013
Higher CD4+ T Cell Counts Associated with Low Viral pol Replication Capacity among Treatment-Naive Adults in Early HIV-1 Infection
JD Barbour, FM Hecht, T Wrin, MR Segal, CA Ramstead, TJ Liegler, ...
The Journal of infectious diseases 190 (2), 251-256, 2004
1112004
Synergy or independence? Deciphering the interaction of HLA Class I and NK cell KIR alleles in early HIV-1 disease progression
JD Barbour, U Sriram, SJ Caillier, JA Levy, FM Hecht, JR Oksenberg
PLoS pathogens 3 (4), e43, 2007
1002007
Human Immunodeficiency Virus Type 1 (HIV-1)-Specific CD8+ TEMRA Cells in Early Infection Are Linked to Control of HIV-1 Viremia and Predict the Subsequent …
JW Northfield, CP Loo, JD Barbour, G Spotts, FM Hecht, P Klenerman, ...
Journal of virology 81 (11), 5759-5765, 2007
962007
Human immunodeficiency virus type 1 superinfection was not detected following 215 years of injection drug user exposure
R Tsui, BL Herring, JD Barbour, RM Grant, P Bacchetti, A Kral, BR Edlin, ...
Journal of virology 78 (1), 94-103, 2004
932004
HIV RNA level in early infection is predicted by viral load in the transmission source
FM Hecht, W Hartogensis, L Bragg, P Bacchetti, R Atchison, R Grant, ...
Aids 24 (7), 941-945, 2010
902010
The system can't perform the operation now. Try again later.
Articles 1–20